title: Genetic variant coding for iron regulatory protein HFE contributes to hypertension, the TAMRISK study.
abstract: Iron is essential for body homeostasis, but iron overload may lead to metabolic abnormalities and thus increase the risk for atherosclerosis and many other diseases. Major histocompatibility complex class I-like transmembrane protein (HFE) is involved in body iron metabolism. The gene coding for HFE has 3 well-known polymorphic sites of which H63D (rs1799945, C > G) has recently been associated with hypertension in a genome-wide association study (GWAS) study. In the present study, we wanted to clarify whether the genetic variant associates with hypertension in a Finnish cohort consisting of 50-year-old men and women. The study included 399 hypertensive cases and 751 controls from the Tampere adult population cardiovascular risk study (TAMRISK) cohort. Genotyping of polymorphisms was done by polymerase chain reaction using DNAs extracted from buccal swabs. We found that individuals with the mutated form of the H63D polymorphic site (G-allele) had a 1.4-fold risk (P = 0.037, 95% confidence interval [CI] 1.02-1.89) for hypertension at the age of 50 years compared with the CC genotype carriers. When obese subjects (body mass index > 30 kg/m²) were analyzed in their own group, the risk for hypertension was even stronger (odds ratio 4.15, P < 0.001, 95% CI 1.98-8.68). We also noticed that the blood pressure (BP) readings were higher in those with the minor G-allele when compared to ones having a normal genotype already at the age of 35 years. Means of systolic/diastolic BPs were 127/81 mm Hg for CC and 131/83 mm Hg for CG + GG groups (P < 0.001 for systolic and P = 0.005 for diastolic pressure). In conclusion, HFE genetic variant H63D was associated with essential hypertension in Finnish subjects from the TAMRISK cohort confirming a previous GWAS study. The effect of this SNP on BP was also confirmed from a longitudinal study.
authors: From the Department of Medical Biochemistry (KMM, STN, TAK), University of Tampere Medical School; and Fimlab Laboratories (STN), Tampere, Finland.
authors: Kirsi M
authors: KM
authors: Määttä
authors: Seppo T
authors: ST
authors: Nikkari
authors: Tarja A
authors: TA
authors: Kunnas
mesh_terms: D016022:Case-Control Studies; D005260:Female; D005387:Finland / Q000453:epidemiology; D020022:Genetic Predisposition to Disease; D005838:Genotype; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I / Q000235:genetics*; D006801:Humans; D006973:Hypertension / Q000453:epidemiology / Q000235:genetics*; D008137:Longitudinal Studies; D008297:Male; D008565:Membrane Proteins / Q000235:genetics*; D008875:Middle Aged; D009765:Obesity / Q000453:epidemiology; D020641:Polymorphism, Single Nucleotide; D011446:Prospective Studies
chemical_list: C103673:HFE protein, human; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I; D008565:Membrane Proteins
references: Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1472-7
references: 9465039
references: Eur J Public Health. 2004 Sep;14(3):235-9
references: 15369026
references: Blood. 2011 Apr 28;117(17):4425-33
references: 21346250
references: World J Nephrol. 2012 Dec 6;1(6):166-76
references: 24175256
references: Am Fam Physician. 2013 Feb 1;87(3):183-90
references: 23418762
references: J Med Genet. 1997 Apr;34(4):275-8
references: 9138148
references: Gastroenterology. 2002 Mar;122(3):646-51
references: 11874997
references: Ann Epidemiol. 2011 Jan;21(1):1-14
references: 20800508
references: Ann Med. 2012 Jun;44 Suppl 1:S2-16
references: 22713144
references: Obes Rev. 2010 Apr;11(4):322-8
references: 19619262
references: Gut. 2001 Jun;48(6):836-42
references: 11358905
references: J Intern Med. 2010 Sep;268(3):246-8
references: 20695974
references: J Hypertens. 2004 Feb;22(2):305-11
references: 15076188
references: Nat Genet. 1996 Aug;13(4):399-408
references: 8696333
references: J Intern Med. 2010 Sep;268(3):252-64
references: 20337854
references: J Hypertens. 2002 Aug;20(8):1513-8
references: 12172312
references: Lancet. 2005 Jan 15-21;365(9455):217-23
references: 15652604
references: Ir J Med Sci. 2014 Jun;183(2):303-9
references: 24000100
references: Am J Gastroenterol. 2000 Oct;95(10):2910-4
references: 11051367
references: Dig Dis Sci. 2006 Apr;51(4):803-7
references: 16615007
references: N Engl J Med. 2004 Jun 3;350(23):2383-97
references: 15175440
references: Nat Med. 2011 Nov 07;17(11):1402-9
references: 22064430
references: Lancet. 2002 Dec 14;360(9349):1903-13
references: 12493255
references: Am J Med Sci. 2013 Jan;345(1):57-60
references: 22627267
references: J Biol Chem. 2011 Apr 15;286(15):13161-70
references: 21349849
references: Int J Hematol. 2008 Jul;88(1):7-15
references: 18594779
references: BMC Med Genet. 2014 Jun 05;15:65
references: 24903457
references: Am J Epidemiol. 2001 Aug 1;154(3):193-206
references: 11479183
references: Nature. 2011 Sep 11;478(7367):103-9
references: 21909115
references: Curr Protein Pept Sci. 2005 Jun;6(3):279-91
references: 15974953